Lutris Pharma to Participate in Virtual Investor Conferences in January
- Tuesday, January 4, 2022, 7:14
- Environment
- Add a comment
TEL AVIV, Israel, Jan. 4, 2022 /PRNewswire/ — Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today announced participation in the following virtual conferences in January: January 10-13: H.C….
About the Author
adminasapcorp has written 41532 stories on this site.